Elite Express Posts $2.53M Loss, $2.15M R&D Spend, and Faces Nasdaq Delisting Risk
ETS has more than doubled off its 52-week low of $0.39 on light trading volume (0.3× avg).
Summary
A $2.15M R&D investment fueled a $2.53M quarterly loss at Elite Express, even as revenue grew 15.3%. The company faces Nasdaq delisting risk and disclosed a material weakness in internal controls.
Key Events · Earnings and Guidance · ETS
-
Net Loss Widens to $2.53M
Driven by a $2.15M R&D expense, the Q2 2026 net loss reached $2,532,942, up from $107,604 a year ago.
-
$2.15M R&D Investment
The company spent $2.15M on R&D for a long-term technology strategy, an amount exceeding three times quarterly revenue.
-
Revenue Up 15.3% to $726,829
Year-over-year revenue increased 15.3%, while gross margin improved to 11.1% from 2.9%.
-
Nasdaq Delisting Risk
Trading at $0.89, the stock remains below the $1.00 Nasdaq minimum; a non-compliance notification was received on April 30, 2026.
Analysis · ETS · Energy & Transportation
A $2.15 million R&D outlay for a long-term technology initiative drove Elite Express to a $2.53 million net loss in Q2 2026, a sharp deterioration from the prior year's $107.6K loss. Revenue grew 15.3% to $726,829 and gross margin improved to 11.1%, but the R&D expense consumed over three times quarterly revenue. The quarter ended with $5.24 million in cash, yet the burn rate and ongoing Nasdaq non-compliance for the $1 minimum bid price create significant uncertainty. Compounding governance concerns, the filing also disclosed a material weakness in internal controls.
At the time of this filing, ETS was trading at $0.89 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $38.3M. The 52-week trading range was $0.39 to $4.23. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.